First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Topline safety, PK, and PD data anticipated in Q1 2026 Advances ongoing ...
HEALWELL, in collaboration with Takeda Pharmaceutical, presented new AI generated and regulatory-grade real-world data (RWD) on vedolizumab dose escalation in ulcerative colitis and Crohn's disease at ...
Healwell AI shares advanced after the company said it demonstrated real-world examples of using artificial intelligence to generate high-quality data for a major pharmaceutical company. Shares traded ...
In the realm of gastroenterology, inflammatory bowel disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), presents a significant therapeutic challenge due to its chronic ...
Saudi Arabia - Jeddah Jeddah hosted recently the 5th Immunology EXPO Forum 2025, with the participation of a group of ...
Foods that may hurt your gut health include ultra-processed and high-fat foods, red meat, artificial sweeteners, alcohol, and ...
Inflammatory Bowel Disease (IBD) affects nearly 500,000 people in the UK. The 'A Chronic Cost' campaign advocates for free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results